P929-0809 Screening compound: 5-[1-(cyclopropylmethyl)-3-(methoxymethyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-methoxypyridine

P929-0809 Screening compound: 5-[1-(cyclopropylmethyl)-3-(methoxymethyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-methoxypyridine
P929-0809 Screening compound: 5-[1-(cyclopropylmethyl)-3-(methoxymethyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-methoxypyridine alternative view

Chemical Structure Depiction of ChemDiv screening compound P929-0809
5-[1-(cyclopropylmethyl)-3-(methoxymethyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-methoxypyridine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P929-0809

Molecular Formula

C19H24N4O3 (C19 H24 N4 O3)

Compound Name

5-[1-(cyclopropylmethyl)-3-(methoxymethyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]-2-methoxypyridine

IUPAC name

5-[1-(cyclopropylmethyl)-3-(methoxymethyl)-1H4H5H6H7H-pyrazolo[43-c]pyridine-5-carbonyl]-2-methoxypyridine

SMILES

COCc1nn(CC2CC2)c(CC2)c1CN2C(c(cc1)cnc1OC)=O

InChI

InChI=1S/C19H24N4O3/c1-25-12-16-15-11-22(19(24)14-5-6-18(26-2)20-9-14)8-7-17(15)23(21-16)10-13-3-4-13/h5-6,9,13H,3-4,7-8,10-12H2,1-2H3

InChI Key

JPUVBRIMXRAEJD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27616073

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

356.42

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.275

Distribution Coefficient, logD

1.275

Water Solubility, LogSw

-1.77

Polar Surface Area

57.033

Acid Dissociation Constant (pKa)

21.43

Base Dissociation Constant (pKb)

1.66

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.63

P929-0809 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

GPCR Targeted Library (31838 compounds)

Hsp90-Targeted Library (11355 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • GPCR
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with P929-0809 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P929-0809?
Check Price and Availability of P929-0809, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P929-0809 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P929-0809
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P929-0809
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P929-0809 available by request